Oncology & Cancer

MicroRNAs 203 and 205 are prognostic in cutaneous SCC

(HealthDay)—MicroRNAs (miR-203 and miR-205) could be useful prognostic markers in cutaneous squamous cell carcinoma, with distinct expression and associations, according to a study published online Dec. 11 in the British ...

Surgery

Microsurgical head and neck reconstruction is cost-effective

(HealthDay)—For patients with squamous cell carcinoma (SCC), microsurgical head and neck reconstruction is cost-effective compared with locoregional flaps, according to a study published online Nov. 29 in Head & Neck.

Oncology & Cancer

Cetuximab + chemoradiation can cure HIV-associated anal cancer

(HealthDay)—Definitive chemoradiation (CRT) can potentially cure HIV-associated squamous cell carcinoma of the anal canal (SCCAC), with the addition of cetuximab resulting in less locoregional failure (LRF), according to ...

Oncology & Cancer

Review: methodological limitations for OSCC biomarkers

(HealthDay)—Methodological concerns have limited the analysis of saliva-based biomarkers for oral squamous cell carcinoma (OSCC), according to a review published online Nov. 29 in Head and Neck.

Oncology & Cancer

Study questions rise of head and neck cancers in the UK

In the first study of its kind researchers from the University of Liverpool's Institute of Translational Medicine have examined the possible reasons for the rapid increase in incidence of particular head and neck cancers ...

page 21 from 36